acebutolol has been researched along with Antibody Deficiency Syndrome in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ballow, M; Berger, M; Bonilla, FA; Buckley, RH; Cunningham-Rundles, CH; Fireman, P; Kaliner, M; Lathia, C; Ochs, HD; Skoda-Smith, S; Sweetser, MT; Taki, H | 1 |
| Anderson, CJ; Buckley, RH; Fischer, SH; Ochs, HD; Pirofsky, B; Rousell, RH; Wedgwood, RJ | 1 |
| Fischer, SH; Ochs, HD; Wedgwood, RJ | 1 |
3 trial(s) available for acebutolol and Antibody Deficiency Syndrome
| Article | Year |
|---|---|
Pharmacokinetics and tolerability of a new intravenous immunoglobulin preparation, IGIV-C, 10% (Gamunex, 10%).
Topics: Adult; Asthenia; Caprylates; Female; Glycine; Half-Life; Humans; Immunoglobulins, Intravenous; Immunologic Deficiency Syndromes; Male; Maltose; Pharmacokinetics; Therapeutic Equivalency; Treatment Outcome | 2003 |
Safety and patient acceptability of intravenous immune globulin in 10% maltose.
Topics: Clinical Trials as Topic; Double-Blind Method; Excipients; Female; Humans; Immune Sera; Immunoglobulins; Immunologic Deficiency Syndromes; Infusions, Parenteral; Male; Maltose | 1980 |
Modified immune globulin: its use in the prophylactic treatment of patients with immune deficiency.
Topics: Clinical Trials as Topic; Humans; Hydrogen-Ion Concentration; Immunoglobulins; Immunologic Deficiency Syndromes; Injections, Intravenous; Maltose | 1982 |